Invetech invited experts in regulatory affairs to share their insights and offer guidance on how to keep clinical development programs moving forward.

Leaders in investment and corporate finance share their perspectives on financing challenges and opportunities for cell and advanced therapy companies.

Invetech explores the expanding role of mass customization in the Consumer Packaged Goods markets.

Hear from an experienced agile trainer/coach and diagnostics industry leaders using agile principles to streamline and improve their development processes.

Our key takeaways from the 2016 World Stem Cells & Regenerative Medicine Congress.

Senior Scientist Rebecca Newman shares her insights on trends in molecular medicine and diagnostics after attending the Molecular Medicine Tri-Conference.

Invetech Marketing Manager Alan Morris relays the insights he gained at the 2016 Phacilitate Cell & Gene Therapy World conference in Washington, D.C.

Representatives from Haemonetics, Quidel and Alameda Health Systems Highland Hospital discuss the future of point of care testing during a webinar hosted by AACC.

Invetech program manager Magnus Ahlstrom shares some of his observations on trends in wearable medical devices after attending Medica 2015.

Additive manufacturing has the possibility to revolutionize the way we approach realizing a product. Associate Principle Engineer Ken Galbraith explains why.

Ludovic Labat goes into detail on key issues when considering Low Cost Region manufacturing.

The IVD industry has the opportunity to not only address world poverty, but also achieve strong commercial return.